SCHEMBL234222

SCHEMBL234222

CCOC(=O)C(CC(=O)c1cccc(OCc2c(C)cccc2C)c1)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.45
MAPK1 P28482 3/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
TSHR P16473 2/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
MAOB P27338 3/20 0.42
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SLC22A12 Q96S37 1/20 0.41
PTPN1 P18031 1/20 0.41
NR4A2 P43354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2756025 0.94 MAPK1 (0.43) TDP1MAPK1L3MBTL1TSHRALDH1A1
SCHEMBL234126 0.89 MAOB (0.47) KMT2AMAOBLMNAMAPTHPGD
SCHEMBL3265205 0.86 KMT2A (0.40) TDP1MAPK1L3MBTL1TSHRALDH1A1
SCHEMBL1008532 0.82 PTPN1 (0.48) ALDH1A1KMT2AMEN1MAOBLMNA
SCHEMBL15300298 0.82 MAOB (0.43) TSHRKMT2AMEN1NPC1MAOB
SCHEMBL237424 0.82 MAOB (0.48) ALDH1A1MAOBLMNAMAPTHPGD
SCHEMBL1634331 0.82 TDP1 (0.52) TDP1L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL1135054 0.81 THRA (0.44) TDP1ALDH1A1KMT2AMAOBLMNA
SCHEMBL1009039 0.81 TDP1 (0.44) TDP1MAPK1L3MBTL1TSHRALDH1A1
SCHEMBL2090098 0.80 ALDH1A1 (0.43) ALDH1A1KMT2AMAOBLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8703991-B2 Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids WELLSTAT THERAPEUTICS CORPORATION (US) 2014-04-22 US claimed
US-20120004442-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS WELLSTAT THERAPEUTICS CORPORATION (US) 2012-01-05 US claimed
EP-2365746-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS Wellstat Therapeutics Corporation (US) 2011-09-21 EP claimed
WO-2010053910-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS WELLSTAT THERAPEUTICS CORPORATION (US) 2010-05-14 WO claimed
US-8703991-B2 Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids WELLSTAT THERAPEUTICS CORPORATION (US) 2014-04-22 US disclosed
US-20120004442-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS WELLSTAT THERAPEUTICS CORPORATION (US) 2012-01-05 US disclosed
EP-2365746-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS Wellstat Therapeutics Corporation (US) 2011-09-21 EP disclosed
WO-2010053910-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS WELLSTAT THERAPEUTICS CORPORATION (US) 2010-05-14 WO disclosed
WO-2010053910-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS WELLSTAT THERAPEUTICS CORPORATION (US) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004442-A1 SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS PGD, HPD, MLYCD TDP1 3194/4885MAPK1 2882/4885L3MBTL1 1451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.